Article Versions Notes

Thomsen CB, Fredslund Andersen R, Jensen LH, Jakobsen A, Frøstrup Hansen T. The Clinical Impact of MicroRNA-21 in Low Rectal Cancer Treated with High-Dose Chemoradiotherapy in the Organ Preserving Setting. Gastrointestinal Disorders. 2020; 2(4):378-384. https://doi.org/10.3390/gidisord2040034

Thomsen, Caroline Brenner, Rikke Fredslund Andersen, Lars Henrik Jensen, Anders Jakobsen, and Torben Frøstrup Hansen. 2020. "The Clinical Impact of MicroRNA-21 in Low Rectal Cancer Treated with High-Dose Chemoradiotherapy in the Organ Preserving Setting" Gastrointestinal Disorders 2, no. 4: 378-384. https://doi.org/10.3390/gidisord2040034

Thomsen, C. B., Fredslund Andersen, R., Jensen, L. H., Jakobsen, A., & Frøstrup Hansen, T. (2020). The Clinical Impact of MicroRNA-21 in Low Rectal Cancer Treated with High-Dose Chemoradiotherapy in the Organ Preserving Setting. Gastrointestinal Disorders, 2(4), 378-384. https://doi.org/10.3390/gidisord2040034